A major concern for “Arpimed” LLC is to provide the consumers with high-quality, effective, and safe drugs, where the benefits of use exceed the possible risks. In order to monitor the safety and efficacy of our medicines, in the company is formed and operates “The Pharmacovigilance Department” which aims to detect, assess, understand and prevent the adverse reactions and problems associated with the use of drugs. Our aim is to detect potential risks for both patients and public health.
There are no absolutely safe medicines! Revealing, registration and analysis of the adverse reactions are necessary for the subsequent specification of the drugs’ indications, contra-indications, side effects, dosages, etc. When adverse events occur, our specialists investigate the causes and make their efforts to minimize and prevent the adverse events in the future.
In case of suspected adverse reactions or inefficiency of the drugs produced by “Arpimed” LLC please fill the below report form or send a format which is convenient to you to our e-mail address.
You will help thousands of patients, if you do just a single simple thing: inform us about the suspected adverse drug reactions…
The long-term strategy of ARPIMED is to provide the population of Armenia and other countries with qualified, effective, safe and affordable medicines.
Sorry, this entry is only available in հայ.
November 1 -3, Arpimed pharmaceutical company participated in the first international scientific conference titled Actual issues of pharmacy and its further development organized by the Institute of Pharmacy of the Yerevan State University dedicated to 75th anniversary of national Academy of Science and 100th anniversary of Yerevan State University. Ani, Ghazaryan, Arpimed Quality manager, presented achievements of the company within 2017-2018: construction of new quality control laboratory and new ophthalmic ointments department in compliance with the international standards of PIC/S GMP.
Varduhi Abrahamyan, microbiologist of QC laboratory, presented the work of Arpimed microbiological laboratory on Development and Validation of Neutralization of antimicrobial activity of Metronidazole denta 1% gel in microbial limit test (co-author Hasmik Arakelyan).
Arpimed has also taken part in the exhibition organized within the frames of the scientific conference.
During the conference, Arpimed participants were headed by the General Director of the company Vachagan Ghazaryan.
We are proud to point out that Arpimed company successfully passed inspection for GMP compliance check-ups carried out by the State Service of Ukraine on Medicines and Drugs Control. Arpimed has been awarded a certificate of compliance with GMP requirements in production of sterile ophthalmic ointments (certificate number: 069/2017/GMP) and was re-awarded a GMP certificate for production of non-sterile medicines with certificate number 068/2017 2017 GMP (first certificate dates to 2014).
International PIC/S GMP certificates prove that the company quality assurance system, production facilities and equipment meet the requirements of Good Manufacturing Practice adopted in Ukraine as well as the requirements of PIC/S, EU and WHO guidelines.
State Service of Ukraine on Medicines and Drugs Control
From 10th-25th October the Quaity Control Laboratory of “Arpimed” LLC headed by Anzhela Grigoryan (head of QCL) organized oral presentations.
Chemists and microbiologists presented their works.
As a result, the company management has awarded the best works:
Hasmik Arakelyan – '' General Microbiology ''
Varduhi Abrahamyan – “TAMC (total aerobic microbial count), TYMC (total combined yeasts and molds count)”
Ashkhen Harutyunyan – “High-performance liquid chromatography”
Rita Avetis – “Infrared spectroscopy”
Armanush Nalbandyan - “UV spectroscopy”